ARTV vs JNPR · $37.3M cap vs P/E 38, $13.36B cap
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Juniper Networks Inc (JNPR) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Juniper Networks Inc (JNPR) is a communication equipment company listed on US.
Latest reported ARTV revenue for 2025-12-31 was $0. Net income was -$83.9M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ARTV currently screens at market cap $37.3M.
JNPR does not have a complete income-statement cache yet.
ARTV currently screens at market cap $37.3M. JNPR currently screens at market cap $13.36B and trailing P/E 38.0.
Not investment advice. Open the ARTV and JNPR stock pages for the full models.
Not investment advice.